Background illustration for clinical trials search

Uterine Cancer Clinical Trials

Browse 340 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

for
Endometrial Endometrioid Adenocarcinoma,
Location: Iowa City IA, Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: Female

Age: 18+

Code: NCT07436793

Phase2, Recruiting

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

for
Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07257055

Phase2, Recruiting

A Study of Ivonescimab in People With Leiomyosarcoma

for
Leiomyosarcoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07516925

Phase2, Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: New York NY, Buffalo NY, Nashville TN, St Louis MO,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

for
CIN - Cervical Intraepithelial Neoplasia, CIN 1, CIN 2, HPV,
Location: London
Sponsor: Papillex Inc.

Sex: Female

Age: 25 - 55

Code: NCT06979180

Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

for
Leiomyosarcoma
Location: Boston MA, New York NY, Miami FL, Columbus OH,
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 0+

Code: NCT05653388

Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Boston MA, Lake Success NY, Fairfax VA, Grand Rapids MI,
Sponsor: STORM Therapeutics LTD

Sex: All

Age: 18+

Code: NCT06975293

Phase1, Phase2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Boston MA, Providence RI, Westerly RI, Waterford CT,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Baltimore MD, Bethesda MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase1, Recruiting

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

for
Leiomyosarcoma, Sarcoma
Location: Columbus OH
Sponsor: Gabriel Tinoco

Sex: All

Age: 18+

Code: NCT06528769

Phase2, Recruiting

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

for
Platinum-Resistant Fallopian Tube Carcinoma,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06483048

Phase1, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Providence RI, Teaneck NJ, Fairfax VA, Cincinnati OH,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06682988

Phase2, Recruiting

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer,
Location: Los Gatos CA
Sponsor: Bay Area Gynecology Oncology

Sex: All

Age: 18 - 70+

Code: NCT02349958

Phase2, Recruiting

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Female

Age: 0+

Code: NCT04469764

Phase2, Recruiting

Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma

for
Recurrent Endometrial Carcinoma,
Location: Miami FL
Sponsor: Aaron Wolfson

Sex: Female

Age: 18+

Code: NCT05603910

Phase1, Recruiting

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

for
Endometrial Cancer, Cervical Cancer
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT06538337

Recruiting

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

for
Cervix Cancer, Cervical Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Female

Age: 18+

Code: NCT06266338

Phase2, Recruiting